1-9 of 9
Fangfang Yan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Novel Insights into SOX11 Modulation of BCR Signaling and Targeting of BTK Resistance

Free
Rudra Prasad Dutta, Heng-Huan Lee, Ravi Prakash Shukla, Violetta V Leshchenko, Fanye Meng, Fangfang Yan, Yang Liu, Husnu Kaniskan, Jian Jin, Lapo Alinari, Michael Wang, Samir Parekh
Journal: Blood
Blood (2024) 144 (Supplement 1): 1402.
https://doi.org/10.1182/blood-2024-210591
Published: 2024
Journal Articles

The Reversible BTK Inhibitor Nemtabrutinib Demonstrates Favorable Antitumor Efficacy and Enhances the Function of CAR T Cells in Mantle Cell Lymphoma

Free
Margaret Elizabeth Simmons, Joseph McIntosh, Tianci Zhang, Yijing Li, Fangfang Yan, Yixin Yao, Lei Nie, Heng-Huan Lee, Wei Wang, Vivian Changying Jiang, Michael Wang, Yang Liu
Journal: Blood
Blood (2023) 142 (Supplement 1): 5789.
https://doi.org/10.1182/blood-2023-187405
Published: 2023
Journal Articles

Predicting CAR-T Response in Mantle Cell Lymphoma Using Deep Neural Network Models on Single-Cell RNA Sequencing Data

Free
Fangfang Yan, Vivian Changying Jiang, Yang Liu, Yijing Li, Yuxuan Che, Preetesh Jain, Lukas Simon, Michael Wang
Journal: Blood
Blood (2023) 142 (Supplement 1): 4377.
https://doi.org/10.1182/blood-2023-187544
Published: 2023
Journal Articles

Exploring BiTE-Integrated CAR T-Cell Therapy to Overcome Tumor Antigen Escape and Reinforce CAR-T Therapy in Mantle Cell Lymphoma

Free
Grace Glass Crutchfield, Yang Liu, Fangfang Yan, Xiaolin Li, Heng-Huan Lee, Michael Wang, Yixin Yao
Journal: Blood
Blood (2023) 142 (Supplement 1): 6820.
https://doi.org/10.1182/blood-2023-190167
Published: 2023
Journal Articles

The Selective CDK9 Inhibitor VIP152 Overcame Therapeutic Resistance in Mantle Cell Lymphoma

Free
William Lee, Vivian Changying Jiang, Tianci Zhang, Fangfang Yan, Qingsong Cai, Joseph McIntosh, Yang Liu, Michael L. Wang
Journal: Blood
Blood (2023) 142 (Supplement 1): 2821.
https://doi.org/10.1182/blood-2023-175035
Published: 2023
Journal Articles

Targeting the HSP90-MYC-CDK9 Axis to Overcome Dual Resistance to BTK Inhibition and CAR-T Therapy in Mantle Cell Lymphoma

Free
Vivian Changying Jiang, Fangfang Yan, Alexa A Jordan, Yuxuan Che, Yang Liu, Qingsong Cai, Yijing Li, Joseph McIntosh, Zhihong Chen, Jovanny Vargas, Yixin Yao, Heng-Huan Lee, Jingling Jin, Wei Wang, Lei Nie, Zhongming Zhao, Lukas M Simon, Michael L. Wang
Journal: Blood
Blood (2022) 140 (Supplement 1): 3512–3513.
https://doi.org/10.1182/blood-2022-163696
Published: 2022
Journal Articles

Dynamic Reprogramming and Evolution Associated with Sequential Resistance to Ibrutinib and CAR T Therapy in Mantle Cell Lymphoma

Free
Fangfang Yan, Changying Jiang, Qingsong Cai, Preetesh Jain, Yijing Li, Yang Liu, Joseph McIntosh, Alexa A Jordan, Zhongming Zhao, Lukas Simon, Michael Wang
Journal: Blood
Blood (2021) 138 (Supplement 1): 2396.
https://doi.org/10.1182/blood-2021-149214
Published: 2021
Journal Articles

Abemaciclib in Combination with Copanlisib to Overcome Therapeutic Resistance in Mantle Cell Lymphoma

Free
Yuxuan Che, Yang Liu, Yijing Li, Joseph McIntosh, Alexa A Jordan, Zhihong Chen, Fangfang Yan, Wei Wang, Jingling Jin, Changying Jiang, Yixin Yao, Michael Wang
Journal: Blood
Blood (2021) 138 (Supplement 1): 2253.
https://doi.org/10.1182/blood-2021-150942
Published: 2021
Journal Articles

Pirtobrutinib Overcomes Ibrutinib and Venetoclax Resistance in Mantle Cell Lymphoma

Free
Yang Liu, Changying Jiang, Fangfang Yan, Joseph McIntosh, Alexa A Jordan, Yijing Li, Yuxuan Che, Qingsong Cai, Wei Wang, Lei Nie, Michael Wang
Journal: Blood
Blood (2021) 138 (Supplement 1): 1182.
https://doi.org/10.1182/blood-2021-151401
Published: 2021